World’s first IV incense formulation
Frankincense (Boswellia Serrata) IV Therapy
World’s first IV incense formulation, Boswellia has been known centuries ago for its positive effects in the treatment of inflammatory diseases. This remarkable Infusion has anti-inflammatory activity by inhibiting inflammatory signalling pathways in the body.
Various clinical trials show efficacy in Crohn’s disease, ulcerative colitis, rheumatoid arthritis and bronchial asthma. Due to its poor oral bioavailability, receiving this unique formulation intravenously, provides 100% bioavailability directly to the bloodstream, ensuring that this resin is directly available to your cells.
£495
Case studies
World's First IV Incense Formulation
Various clinical trials show efficacy in Crohn’s disease, ulcerative colitis, rheumatoid arthritis and bronchial asthma.
Enquire Today
To learn more about Frankincense IV Therapy or any of our other IV therapies, please request an appointment at info@nuutro.co.uk